Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
- 22 January 2005
- Vol. 23 (24) , 3202-3209
- https://doi.org/10.1016/j.vaccine.2004.11.075
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in miceVaccine, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Serologic and Molecular Biologic Methods for SARS-associated Coronavirus Infection, TaiwanEmerging Infectious Diseases, 2004
- The clinical pathology of severe acute respiratory syndrome (SARS): a report from ChinaThe Journal of Pathology, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003
- Koch's postulates fulfilled for SARS virusNature, 2003
- Coronavirus as a possible cause of severe acute respiratory syndromeThe Lancet, 2003
- Antibody-Dependent Enhancement of Feline Infectious Peritonitis Virus Infection in Feline Alveolar Macrophages and Human Monocyte Cell Line U937 by Serum of Cats Experimentally or Naturally Infected with Feline Coronavirus.The Journal of Veterinary Medical Science, 1998